ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NATCOPHARM announcements Natco Pharma Limited announcements and dividends declared NSE

Natco Pharma Limited Complete list of announcements declared & dividend announcements by Natco Pharma Limited NATCOPHARM

Natco Pharma Limited NATCOPHARM listed on NSE and deals in Pharmaceuticals

Announcements and dividends declared by Natco Pharma Limited NATCOPHARM

Natco Pharma Q1 profit falls 57 pc to Rs 206.5 cr
Natco Pharma has reported a stark profit decline in the first quarter, largely driven by reduced sales of its leading cancer drug, lenalidomide. This led to a pronounced drop in consolidated revenues compared to the prior year. On a brighter note, the core
Announcement as on 14 August 2026

Natco Pharma Q1 results: Profit falls 57% to ?206 cr, revenue at ?735 cr
Natco Pharma Ltd on Friday reported a 57 per cent decline in consolidated net profit at Rs 206.5 crore in the first quarter ended June 2026, hit by lower sales of its generic cancer treatment drug lenalidomide. The company had posted a consolidated net pro
Announcement as on 14 August 2026

Board Meeting to discuss
Fund Raising To consider Fund Raising
Announcement as on 12 August 2026

Company Announcement
Natco Pharma Limited has informed the Exchange about Schedule of meet
Announcement as on 12 August 2026

Company Announcement

Announcement as on 12 August 2026

Announcements by Natco Pharma Limited first page | Next page | Prev page |

NATCOPHARM Natco Pharma Limited current price & indicator signals

Moving Averages for Natco Pharma Limited

  • 5Day Average: 786.06
  • 12Day Average: 788.53
  • 20Day Average: 791.91
  • 50Day Average: 818.55
  • 100Day Average: 869.06
  • 150Day Average: 937.94
  • 200Day Average: 928.09

NATCOPHARM Indicators & signals

Indicator MACD (12,26,9)

789.19, 800.11, -12.18
Indicator MACD is in negative zone

Indicator ADX (14)

13.72, 12.24, 16.13
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 47
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NATCOPHARM Natco Pharma Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
03 Tue Nov 2026 781.60 779.20 to 794.90 -0.53% 0.65 times
02 Mon Nov 2026 785.75 780.95 to 791.75 0.43% 0.41 times
30 Fri Oct 2026 782.40 779.50 to 800.90 -0.65% 0.65 times
29 Thu Oct 2026 787.55 785.90 to 799.45 -0.69% 0.46 times
28 Wed Oct 2026 793.00 779.05 to 802.00 -0.2% 1.7 times
27 Tue Oct 2026 794.55 785.50 to 798.85 0.55% 0.88 times
26 Mon Oct 2026 790.20 782.60 to 796.05 -0.21% 0.82 times
23 Fri Oct 2026 791.85 778.00 to 797.45 0.85% 1.15 times
22 Thu Oct 2026 785.15 773.60 to 789.00 0.09% 1.41 times
21 Wed Oct 2026 784.45 780.00 to 800.65 -2.05% 0.97 times
19 Mon Oct 2026 800.85 779.50 to 809.80 2.01% 1.55 times
16 Fri Oct 2026 785.05 780.95 to 788.50 0.01% 1.01 times

Videos related to: NATCOPHARM announcements Natco Pharma Limited announcements and dividends declared NSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

NATCOPHARM announcements Natco Pharma Limited announcements and dividends declared NSE

 

Back to top